scholarly journals α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

BMC Cancer ◽  
2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Yasuto Akiyama ◽  
Chie Oshita ◽  
Akiko Kume ◽  
Akira Iizuka ◽  
Haruo Miyata ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Dendritic Cell ◽  
Phase I ◽  
High Grade Glioma ◽  
Phase I Clinical Trial ◽  
High Grade

Phase I Clinical Trial Assessing Temozolomide and Tamoxifen With Concomitant Radiotherapy for Treatment of High-Grade Glioma

2012 ◽  
Vol 82 (2) ◽  
pp. 739-742 ◽  
Author(s):  
Shilpen Patel ◽  
Steven DiBiase ◽  
Barry Meisenberg ◽  
Todd Flannery ◽  
Ashish Patel ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
High Grade Glioma ◽  
Phase I Clinical Trial ◽  
High Grade ◽  
Concomitant Radiotherapy

Prognostic value of 18F-FET PET imaging in re-irradiation of high-grade glioma: Results of a phase I clinical trial

2016 ◽  
Vol 121 (1) ◽  
pp. 132-137 ◽  
Author(s):  
Soren Moller ◽  
Ian Law ◽  
Per Munck af Rosenschold ◽  
Junia Costa ◽  
Hans Skovgaard Poulsen ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Pet Imaging ◽  
Prognostic Value ◽  
High Grade Glioma ◽  
Phase I Clinical Trial ◽  
High Grade ◽  
Fet Pet

Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial

2020 ◽  
Vol 40 (11) ◽  
pp. 6473-6484
Author(s):  
KOICHI MITSUYA ◽  
YASUTO AKIYAMA ◽  
AKIRA IIZUKA ◽  
HARUO MIYATA ◽  
SHOICHI DEGUCHI ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Dendritic Cell ◽  
Phase Ii ◽  
High Grade Glioma ◽  
Phase Ii Clinical Trial ◽  
High Grade ◽  
Newly Diagnosed ◽  
Alpha Type
Sign in / Sign up

Export Citation Format

Share Document